Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several ...

It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...

Swiss drugmaker Novartis predicted that the Australian government would not defend its nuclear medicine world technology ...

We need a different way to pay for these “miracle” drugs. One option is to have them paid for on an annual basis, spreading the cost over the patient’s estimated lifespan, with payment to stop if the ...